SHE:002007

2 stories mentioning SHE:002007Updated just now

Every FINWIRES story that references SHE:002007, newest first.

Hualan Biological Subsidiary Gets China Nod for mRNA Flu Vaccine Trial

Hualan Biological Engineering (SHE:002007) subsidiary Hualan Biological Vaccine received clinical trial approval from China's National Medical Products Administration for its novel influenza virus mRNA vaccine.The drug is used to prevent influenza with vaccine-matched flu virus strains, according to a Tuesday filing with the Shenzhen bourse.The drug company's shares fell 2% during afternoon trading on Tuesday.

SHE:002007

Asia92d ago

Hualan Gets China Clinical Trial Approval for Influenza Jab

China's drug regulator approved Hualan Biological Engineering (SHE:002007) subsidiary Hualan Biological Vaccine's clinical trial for its novel adjuvanted influenza virus split vaccine.The vaccine helps with immunity against influenza, especially in elderly and immunocompromised patients, according to a Saturday disclosure to the Shenzhen bourse.

SHE:002007

Track with the FINWIRES app suite

FolioX

Track SHE:002007 in your portfolio

WheelAI

Analyze SHE:002007 options with the wheel strategy

StockInsider

See market sentiment on SHE:002007